135 related articles for article (PubMed ID: 3512075)
21. Recombinant human prolactin improves antitumor effects of murine natural killer cells in vitro and in vivo.
Sun R; Wei H; Zhang J; Li A; Zhang W; Tian Z
Neuroimmunomodulation; 2002-2003; 10(3):169-76. PubMed ID: 12481157
[TBL] [Abstract][Full Text] [Related]
22. Pronounced antitumor effect of LAK-like cells induced in the peritoneal cavity of mice after intraperitoneal injection of OK-432, a killed streptococcal preparation.
Saito M; Ichimura O; Kataoka M; Moriya Y; Ueno K; Sugawara Y; Nanjo M; Ishida N
Cancer Immunol Immunother; 1986; 22(3):161-8. PubMed ID: 2425968
[TBL] [Abstract][Full Text] [Related]
23. Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity.
Kawase I; Komuta K; Hara H; Inoue T; Hosoe S; Ikeda T; Shirasaka T; Yokota S; Tanio Y; Masuno T
Cancer Res; 1988 Mar; 48(5):1173-9. PubMed ID: 3257715
[TBL] [Abstract][Full Text] [Related]
24. Activation of natural killer cells by Bacillus Calmette-Guérin.
Brandau S; Böhle A
Eur Urol; 2001 May; 39(5):518-24. PubMed ID: 11464031
[TBL] [Abstract][Full Text] [Related]
25. Synergistic antitumor effects of BCG and monoclonal antibodies capable of inducing antibody-dependent cell-mediated cytotoxicity.
Komuta K; Kawase I; Ogura T; Masuno T; Yokota S; Hosoe S; Ikeda T; Shirasaka T; Kishimoto S
Jpn J Cancer Res; 1987 Feb; 78(2):185-92. PubMed ID: 3104261
[TBL] [Abstract][Full Text] [Related]
26. Immunoprophylaxis of a murine bladder cancer with high dose BCG immunizations.
Pang AS; Morales A
J Urol; 1982 May; 127(5):1006-9. PubMed ID: 7086976
[TBL] [Abstract][Full Text] [Related]
27. Reduction of bladder cancer growth in mice treated with intravesical Bacillus Calmette Guerin and systemic interleukin 2.
Lee KE; Weiss GH; O'Donnell RW; Cockett AT
J Urol; 1987 Jun; 137(6):1270-3. PubMed ID: 3495671
[TBL] [Abstract][Full Text] [Related]
28. Enhancement of NK-cell activity in normal and tumor-bearing mice after administration of aclacinomycin.
Andrade Mena CE; Orbach-Arbouys S; Mathé G
Chemotherapy; 1986; 32(2):142-7. PubMed ID: 3698723
[TBL] [Abstract][Full Text] [Related]
29. [Injection of interleukin-2 (IL-2) into the tumor-bearer's spleen augments lymphokine-activated killer (LAK) activity in vitro and inhibits tumor metastasis].
Okuno K; Ohnishi H; Takagi H; Nakamura T; Kokudo S; Yasutomi M
Nihon Geka Gakkai Zasshi; 1987 Jul; 88(7):802-7. PubMed ID: 3499562
[TBL] [Abstract][Full Text] [Related]
30. Cytotoxic cells induced during lymphocytic choriomeningitis virus infection of mice: natural killer cell activity in cultured spleen leukocytes concomitant with T-cell-dependent immune interferon production.
Welsh RM; Doe WF
Infect Immun; 1980 Nov; 30(2):473-83. PubMed ID: 6160108
[TBL] [Abstract][Full Text] [Related]
31. [Changes in the activity of natural killer cells in superficial bladder cancer during intravesical BCG therapy].
Samodai L; Dankó K
Orv Hetil; 1992 Sep; 133(36):2283-6, 2291-2. PubMed ID: 1408062
[TBL] [Abstract][Full Text] [Related]
32. Analysis of the immunologic mechanism of intravesical bacillus Calmette-Guerin therapy for superficial bladder tumors: distribution and function of immune cells.
Chung JY; Lee ES; Lee WJ; Kim HH; Min KJ; Lee C
J Korean Med Sci; 1993 Apr; 8(2):135-44. PubMed ID: 8397930
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-10 inhibits Mycobacterium bovis bacillus Calmette-Guérin (BCG)-induced macrophage cytotoxicity against bladder cancer cells.
Luo Y; Han R; Evanoff DP; Chen X
Clin Exp Immunol; 2010 Jun; 160(3):359-68. PubMed ID: 20148913
[TBL] [Abstract][Full Text] [Related]
34. Upregulation of natural killer cells functions underlies the efficacy of intratumorally injected dendritic cells engineered to produce interleukin-12.
Rodríguez-Calvillo M; Duarte M; Tirapu I; Berraondo P; Mazzolini G; Qian C; Prieto J; Melero I
Exp Hematol; 2002 Mar; 30(3):195-204. PubMed ID: 11882356
[TBL] [Abstract][Full Text] [Related]
35. Allogeneic blood transfusion reduces murine pulmonary natural killer (NK) activity and enhances lung metastasis of a syngeneic tumour.
Clarke PJ; Burton RC; Wood KJ
Int J Cancer; 1993 Dec; 55(6):996-1002. PubMed ID: 8253537
[TBL] [Abstract][Full Text] [Related]
36. Combined effect of interleukin 2 and bacillus Calmette-Guérin in the therapy of mice with transitional cell carcinoma.
Ikemoto S; Kamizuru M; Wada S; Nishio S; Kishimoto T; Maekawa M
Urol Int; 1991; 47(4):250-4. PubMed ID: 1781111
[TBL] [Abstract][Full Text] [Related]
37. Myeloid-derived suppressor cells confer tumor-suppressive functions on natural killer cells via polyinosinic:polycytidylic acid treatment in mouse tumor models.
Shime H; Kojima A; Maruyama A; Saito Y; Oshiumi H; Matsumoto M; Seya T
J Innate Immun; 2014; 6(3):293-305. PubMed ID: 24192491
[TBL] [Abstract][Full Text] [Related]
38. Sustained effector function of IL-12/15/18-preactivated NK cells against established tumors.
Ni J; Miller M; Stojanovic A; Garbi N; Cerwenka A
J Exp Med; 2012 Dec; 209(13):2351-65. PubMed ID: 23209317
[TBL] [Abstract][Full Text] [Related]
39. Blastogenesis of large granular lymphocytes in nonlymphoid organs.
McIntyre KW; Natuk RJ; Biron CA; Kase K; Greenberger J; Welsh RM
J Leukoc Biol; 1988 Jun; 43(6):492-501. PubMed ID: 2837525
[TBL] [Abstract][Full Text] [Related]
40. BCG-activated NK cells regulate the antibody response to SRBC and restore immune reactivity to PPD in BCG-infected mice.
Falcone V; Marelli P; Zolfino I; Campa M
Immunol Lett; 1993 Jun; 36(3):295-9. PubMed ID: 8370601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
